Litigation Details for Northwestern University v. Moderna, Inc. (D. Del. 2024)
✉ Email this page to a colleague
Northwestern University v. Moderna, Inc. (D. Del. 2024)
Docket | ⤷ Sign Up | Date Filed | 2024-10-16 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:1 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | Plaintiff | Referred To | |
Patents | 9,283,287; 9,572,897 | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Northwestern University v. Moderna, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Northwestern University v. Moderna, Inc. (D. Del. 2024)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2024-10-16 | 1 | Complaint | its other U.S. patents: U.S. Patent Nos. 8,822,663, 8,980,864, 9,254,311, 9,283,287, 9,464,124, 9,572,897… The Patent Office issued U.S. Patent No. 9,216,155 on December 22, 2015. The ’155 patent is titled…. The Patent Office issued U.S. Patent No. 10,328,026 on June 25, 2019. The ’026 patent is titled… The Patent Office issued U.S. Patent No. 8,323,686 on December 4, 2012. The ’686 patent is titled…and ’026 patents are referred to as the Asserted Patents. 74. The Asserted Patents provided | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |